Sciclone Pharma (SCLN) Misses Q1 EPS by 2c; Guides FY11 EPS Above
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Sales and marketing: 13.32M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Sales and marketing: 13.32M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q1 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $21.7 million versus the consensus estimate of $24.32 million.
Sciclone Pharmaceuticals, Inc. sees FY2011 non-GAAP EPS of $0.52-$0.57, versus the consensus of $0.46.
Sciclone Pharmaceuticals, Inc. sees FY2011 non-GAAP EPS of $0.52-$0.57, versus the consensus of $0.46.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FI) Tops Q1 EPS by 9c; Boosts outlook
- Texas Instruments (TXN) jumps as on earnings, revenue beat in fiscal Q1
- Texas Instruments (TXN) Tops Q1 EPS by 13c, Beats on Revenue; Offers Q2 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
